High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma CellsLindy Vernooij, M. Emmy M. Dolman|Molecular Cancer Therapeutics|2021Cited by 18